Orphenadrine Citrate is the citrate salt form of orphenadrine with a muscle relaxant property. Although the mechanism of action has not been fully elucidated, orphenadrine citrate appears to block cholinergic receptors, thereby interfering with the transmission of nerve impulses from the spinal cord to the muscles. It does not produce myoneural block, nor does it affect crossed extensor reflexes. It is grouped under the following drug class(es): Anticholinergics. Its therapeutic use is listed as central nervous system (CNS) agents and muscle relaxants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Banflex, Flexon, X-Otag, Flexoject and Plenactol. Its PubChem CID is 83823.
Orphenadrine citrate
| CAS No | 4682-36-4 |
|---|---|
| Molecular Formula | C24H31NO8 |
| Molecular Weight | 461.5 g/mol |
| Synonyms | N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Orphenadrine Citrate is the citrate salt form of orphenadrine with a muscle relaxant property. Although the mechanism of action has not been fully elucidated, orphenadrine citrate appears to block cholinergic receptors, thereby interfering with the transmission of nerve impulses from the spinal cord to the muscles.
The listed CAS number is 4682-36-4.
The listed molecular formula is C24H31NO8.
The listed molecular weight is 461.5 g/mol.
N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid.
The source lists Banflex, Flexon, X-Otag, Flexoject and Plenactol.